XML 35 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Intangible Assets and Goodwill
9 Months Ended
Sep. 27, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill INTANGIBLE ASSETS AND GOODWILL
Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.
(Dollars in Millions)September 27, 2020December 29, 2019
Intangible assets with definite lives:  
Patents and trademarks — gross$38,381 36,634 
Less accumulated amortization16,098 13,154 
Patents and trademarks — net22,283 23,480 
Customer relationships and other intangibles — gross22,455 22,056 
Less accumulated amortization10,427 9,462 
Customer relationships and other intangibles — net*12,028 12,594 
Intangible assets with indefinite lives:  
Trademarks6,995 6,922 
Purchased in-process research and development (1)
5,700 4,647 
Total intangible assets with indefinite lives12,695 11,569 
Total intangible assets — net$47,006 47,643 
*The majority is comprised of customer relationships
(1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.

Goodwill as of September 27, 2020 was allocated by segment of business as follows:
(Dollars in Millions)Consumer HealthPharmaceuticalMedical DevicesTotal
Goodwill at December 29, 2019$9,736 9,169 14,734 33,639 
Goodwill, related to acquisitions— 183 184 
Currency translation/Other171 280 33 484 
Goodwill at September 27, 2020$9,907 9,450 14,950 34,307 

The weighted average amortization period for patents and trademarks is 12 years. The weighted average amortization period for customer relationships and other intangible assets is 21 years. The amortization expense of amortizable intangible assets included in cost of products sold was $1.2 billion and $1.1 billion for the fiscal third quarters ended September 27, 2020 and September 29, 2019, respectively. The amortization expense of amortizable intangible assets included in cost of products sold was $3.4 billion and $3.3 billion for the fiscal nine months ended September 27, 2020 and September 29, 2019, respectively. Intangible asset write-downs are included in Other (income) expense, net.


The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:
(Dollars in Millions)
20202021202220232024
$4,5004,3004,1004,1003,900

See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.